In the present work the aim is to successfully
develop a formulation in the form of buccal patch which
has prolong residence time also for addressing the
problem of osteoporosis in infected teeth. Patients can
control the period of administration or terminate
delivery in case of emergencies. The buccal drug delivery
systems easily administered into the buccal cavity. The
novel buccal dosage forms Exhibits better patient
compliance. The formulation F4 is selected for best
formulation because its show the 98.85% drug release at
time 6 hr, folding endurance is 189+4 times and weight
of prepared film is 95+4 mg and thickness 43+2 mm of
these formulations respectively.
Keywords : Ketorolac, Mucoadhesive, Formulation and Evaluation of Buccal Film, Solvent Casting, Buccal Film.